Read More
<table class="tr-caption-container" style="float: right; margin-left: 1em; text-align: right;" cellpadding="0" cellspacing="0">
<tbody>
<tr>
<td style="text-align: center;"><a href="http://3.bp.blogspot.com/-jfbWgrplfaU/VFuS4CaFc-I/AAAAAAAADIA/LdW1wE6PyeE/s1600/Misconceptions.jpg" imageanchor="1" style="clear: right; margin-bottom: 1em; margin-left: auto; margin-right: auto;"><img src="http://3.bp.blogspot.com/-jfbWgrplfaU/VFuS4CaFc-I/AAAAAAAADIA/LdW1wE6PyeE/s1600/Misconceptions.jpg" height="188" border="0" width="200" /></a></td>
</tr>
<tr>
<td class="tr-caption" style="text-align: center;"> http://andreyev.com.au/wp-content/uploads/Misconceptions.jpg</td>
</tr>
</tbody>
</table>
<div class="MsoListParagraphCxSpFirst" style="margin-left: 0in; mso-add-space: auto;"><span style="font-family: 'Arial',sans-serif;">We blogged recently about </span><a href="http://roosterbio.blogspot.com/2014/10/current-bottlenecks-in-msc-research.html"><span style="font-family: 'Arial',sans-serif;">Mesenchymal Stem/Stromal Cell (MSC) Misconceptions</span></a><span style="font-family: 'Arial',sans-serif;"> that are holding the translational cell therapy field back, as identified by </span><a href="http://www.scripps.edu/florida/philanthropy/action/phinney-profile.html"><span style="font-family: 'Arial',sans-serif;">Donald Phinney</span></a><span style="font-family: 'Arial',sans-serif;"> and </span><a href="http://www.stromalab.fr/index.php?option=com_content&amp;view=article&amp;id=86&amp;lang=en"><span style="font-family: 'Arial',sans-serif;">Luc Sensebé</span></a><span style="font-family: 'Arial',sans-serif;">. Since we have come to market with our own hMSC product lines, we have spoken with hundreds of MSC researchers and engineers, and we have compiled our own...</span></div> Read More

We blogged several months ago about bottlenecks in the bioprocessing of Mesenchymal Stem Cellsthat are impeding their clinical translation. While the development of robust and scalable manufacturing methods, reduced cost of goods, and implementation of solid Quality Systems are all necessary for increased clinical use of MSCs, there are also current misconceptions surrounding MSCs, rooted in...
Read More

Mesenchymal stem cells (MSCs)aggregated into three-dimensional (3D) cellular spheroids are a potent configuration for cell therapy and tissue engineering research and product development (5), and cellular spheroids are a preferred format for many bioprinting applications (10). Cellular spheroids are essentially micro-tissues that can be manufactured as standardized “living materials” with certain...
Read More